Advertisement
Advertisement

MDCX

MDCX logo

Medicus Pharma Ltd. Common Stock

1.25
USD
Sponsored
+0.07
+6.02%
Jan 29, 16:00 UTC -5
Closed
exchange

After-Market

1.26

+0.01
+1.12%

MDCX Earnings Reports

Positive Surprise Ratio

MDCX beat 2 of 8 last estimates.

25%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.15
Implied change from Q3 25 (Revenue/ EPS)
--
/
-76.92%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-16.67%

Medicus Pharma Ltd. Common Stock earnings per share and revenue

On Nov 14, 2025, MDCX reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.29 USD, resulting in a -119.74% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.15 USD, with revenue projected to reach -- USD, implying an decrease of -76.92% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Medicus Pharma Ltd. Common Stock reported EPS of -$0.65, missing estimates by -119.74%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.55%, changed from $2.20 before the earnings release to $2.30 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 6 analysts, Medicus Pharma Ltd. Common Stock is expected to report EPS of -$0.15 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement